once monthly glp 1 agonist ADA 2026 confirmed what many of us have been anticipating for years. We're entering a new era of obesity medicine: triple agonists, oral GLP-1s, injections, and therapies targeting obesity, diabetes, and Indications for GLP-1/GIP RA Summary

WangJJYangHLZhangDQFuGSYinYXJiangXet al

Recent final draft guidance from NICE (2026a) has recommended semaglutide up to a dose of 2.4 mg subcutaneously once weekly for people without diabetes and: with pre-existing CVD (previous MI, stroke or peripheral vascular disease) and a BMI of 27 kg/m 2 for CV protection (to reduce CV death, non-fatal MI, non-fatal stroke)

Having them immediately available reduces the anxiety around potential embarrassing moments

How to Get Started If you're interested in the GLP-1 Bridge: Talk to your doctor about whether you meet the clinical eligibility criteria Your doctor will submit a prior authorization request (processed centrally by Humana) If approved, fill your prescription at a participating pharmacy Pay your $50 monthly copay What Happens After the Bridge